Changing our world through 3D visualization.
The Oculenz AMD AR/XR headset (for low-vision patients) and StereoLenz 3D monitor (which allows users to see a 3D image without 3D glasses) are nearing commercialization, with seven additional products forthcoming. Reach out to get involved.
Get in Touch
The company is currently acquiring capital, collecting pre-orders, and recruiting medical and scientific boards members.
Ocutrx obtains investments through referrals, and our Investor Relations team. For more information, please contact us.
Our Patents
16 Issued
Eye-tracking, AR
Visual field test, AR
Dynamic Opacity
Foveated Rendering
Telehealth Monitoring
Optical Engine
116 Pending
45 patent families
MedTiles, ORLenz, Or-Bot & Scopetrx have been filed and are pending.
160+ Expected
Additional patents have been filed on features such as micro-displays, applications, connectivity, and more.